(Q39399138)

11 September 2017

title

MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma (English)

1 reference

11 September 2017

Youtao Yu

1

1 reference

11 September 2017

Yubao Zhang

2

1 reference

11 September 2017

Jianran Hu

3

1 reference

11 September 2017

Hao Zhang

4

1 reference

11 September 2017

Shan Wang

5

1 reference

11 September 2017

Fang Han

6

1 reference

11 September 2017

Lei Yue

7

1 reference

11 September 2017

Youpeng Qu

8

1 reference

11 September 2017

Yao Zhang

9

1 reference

11 September 2017

Hongjian Liang

10

1 reference

11 September 2017

Huan Nie

11

1 reference

11 September 2017

Yu Li

12

1 reference

11 September 2017

publication date

8 March 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

103

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

716-722

1 reference

Hepatocellular carcinoma: diagnosis and treatment

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Molecular viral oncology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Focus on hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Hepatocellular carcinoma pathogenesis: from genes to environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Novel treatments for hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Down-regulation of members of glycolipid-enriched membrane raft gene family, MAL and BENE, in cervical squamous cell cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Identification and characterization of MARVELD1, a novel nuclear protein that is down-regulated in multiple cancers and silenced by DNA methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Loss of occludin affects tricellular localization of tricellulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

MAL regulates clathrin-mediated endocytosis at the apical surface of Madin-Darby canine kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Utility of DNA methylation markers for diagnosing cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

ERK implication in cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

The tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Minireview: Cyclin D1: normal and abnormal functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02220.X

High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22320884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22320884

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1349-7006.2012.02220.X

1 reference

11 September 2017

1 reference